Opportunity Information: Apply for CDC RFA GH15 15440201SUPP16
Apply for CDC RFA GH15 15440201SUPP16
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Program Expansion Supplement for Implementation of Sustainable Laboratory Quality Systems in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Jul 29, 2016.
- Applicants must submit their applications by Sep 27, 2016 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $401,462.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Program Expansion Supplement for Implementation of Sustainable Laboratory Quality Systems in the Republic of Kenya under PEPFAR," is a CDC cooperative agreement designed to strengthen Kenya's medical laboratory systems so they can better diagnose, manage, and track HIV, tuberculosis (TB), and related opportunistic infections. The central idea is to provide hands-on technical assistance to the Government of Kenya and PEPFAR implementing partners, with an emphasis on building systems that last: stronger policies, stronger networks, better quality, safer practices, and more reliable testing services across the country.
The program is structured around regional support. Up to five grantees may be selected, and each grantee will be assigned to work in one of four defined regions (A, B, C, and D) that collectively cover multiple counties. Each regional grantee is expected to support all technical areas described in the announcement within their assigned region. Region A comes with an added national-level responsibility: the grantee working in Region A must also support laboratory systems at the National Public Health Laboratory Services and at the Ministry of Health headquarters. This setup reflects a two-tier focus: county and regional implementation combined with national coordination and standard-setting, especially in the region that carries the additional headquarters function.
The first major component of the work is broad laboratory systems strengthening. Grantees are expected to help develop and improve laboratory policies and operational systems covering sample handling and processing, laboratory networking and referral linkages, laboratory information management, supply chain and supplies management, workforce and human capacity development, biosafety, quality management systems (QMS), and monitoring and evaluation. A key practical goal within this component is expanding access to high-quality testing by improving tiered laboratory networks and specimen referral systems. The FOA specifically highlights priority diagnostic and monitoring services such as CD4 testing, early infant diagnosis (EID) for HIV, HIV viral load testing, detection of opportunistic diseases, TB culture capacity, and HIV/TB drug resistance testing. In other words, the program is not only concerned with individual laboratories performing better, but also with the entire pathway that makes testing possible at scale: getting the right specimen from the right facility to the right lab, processing it correctly, reporting results quickly, and using those results for patient care and public health action.
A second technical area focuses on safe and appropriate blood use and haemovigilance at facilities that transfuse patients. The expectation is that grantees will provide technical expertise to improve transfusion practices through the establishment of hospital transfusion committees. These committees typically serve as the internal governance mechanism in a hospital for overseeing blood ordering, storage, administration practices, adverse event monitoring, and continuous improvement. By pushing for formal transfusion committees, the program aims to reduce preventable transfusion-related harm and ensure blood products are used appropriately and monitored systematically.
The third major area emphasizes safety and risk reduction within laboratory and clinical environments, specifically biosafety, infection control, occupational health and safety, and medical waste management. This includes strengthening practices and systems that protect laboratory staff, clinicians, patients, and surrounding communities. The FOA frames this as a measurable improvement area, aiming to increase the number of laboratories meeting minimum national biosafety and medical waste standards. In practice, this often means improved procedures, training, personal protective equipment use, safe handling and disposal protocols, and clearer accountability for compliance with national standards.
Across these technical areas, the FOA sets out several headline outcomes expected by the end of the project period. One is increased access to quality HIV and TB laboratory tests, reflecting improved availability, reliability, and reach of essential diagnostic and monitoring services. Another is a major push on quality management and accreditation using the SLIPTA approach (Strengthening Laboratory Improvements towards Accreditation), a stepwise framework commonly used in Africa to build laboratory QMS maturity toward internationally recognized standards. The FOA calls for establishing at least two model SLIPTA laboratories in each county and achieving ISO 15189 accreditation for at least two laboratories in each county, which signals an ambitious quality target. Additional expected outcomes include more laboratories meeting national biosafety and waste management standards and more health facilities establishing hospital transfusion committees and implementing best practices in transfusion and haemovigilance. The FOA notes that more detailed short-, intermediate-, and long-term outcomes are laid out in the program's logic model, which would serve as the reference for how activities are expected to translate into measurable results over time.
Accountability and performance monitoring are built into the award. Grantees must provide quarterly activity progress reports and quarterly budget updates to the CDC Kenya team, creating a regular cadence for technical oversight and financial monitoring. Grantees are also expected to conduct mid-term and end-term program reviews, which function as structured checkpoints to assess whether implementation is on track and to make course corrections. Beyond routine reporting, the FOA explicitly calls for both process and outcome evaluations to measure progress toward the goals and objectives across the four technical areas described, with a clear expectation that findings will be disseminated and used for program improvement rather than simply filed away.
Administratively, this is a discretionary funding opportunity issued by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (specifically CDC CGH). The funding instrument is a cooperative agreement, which usually implies substantial CDC involvement in guiding implementation, providing technical direction, and collaborating on strategy and performance expectations. The opportunity is listed under CFDA 93.067. It was originally posted July 29, 2016, with an original application deadline of September 27, 2016 (electronic submissions due by 11:59 p.m. ET). The published award ceiling is $401,462, and the announcement lists an expected number of awards as 1, while also describing a model of up to five grantees working across four regions, suggesting the posted record reflects a specific supplement or funding action within a broader program structure. Eligibility is described as "Others" with additional clarification referenced in the full eligibility text.
Taken together, the FOA is essentially a systems-building and quality-improvement initiative for Kenya's laboratory and transfusion services under PEPFAR: expand access to priority HIV/TB testing, build functioning referral networks and information systems, improve safety and waste management, strengthen transfusion governance through hospital committees, and drive measurable laboratory quality improvements using SLIPTA and ISO 15189 accreditation targets, all tracked through frequent reporting and formal evaluations aimed at continuous program improvement.
Frequently Asked Questions (FAQs)
1) What is the title of this funding opportunity?
The opportunity is titled "Program Expansion Supplement for Implementation of Sustainable Laboratory Quality Systems in the Republic of Kenya under PEPFAR."
2) Who is offering this grant opportunity?
This is a U.S. government discretionary funding opportunity issued by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), specifically CDC CGH.
3) What type of funding instrument is this?
The funding instrument is a cooperative agreement. In cooperative agreements, CDC typically has substantial involvement in implementation, including technical direction, collaboration on strategy, and alignment on performance expectations.
4) What is the CFDA number for this opportunity?
The opportunity is listed under CFDA 93.067.
5) What is the overall purpose of the program?
The program is designed to strengthen Kenya's medical laboratory systems so they can better diagnose, manage, and track HIV, tuberculosis (TB), and related opportunistic infections. The emphasis is on hands-on technical assistance and building systems that are sustainable over time.
6) What does "systems strengthening" mean in the context of this program?
In this FOA, systems strengthening includes improving laboratory policies and operational systems across areas such as sample handling and processing, laboratory networking and referral linkages, laboratory information management, supply chain and supplies management, workforce and human capacity development, biosafety, quality management systems (QMS), and monitoring and evaluation.
7) What diseases and testing priorities are emphasized?
The FOA highlights HIV and TB, as well as opportunistic infections. Priority diagnostic and monitoring services specifically mentioned include CD4 testing, early infant diagnosis (EID) for HIV, HIV viral load testing, detection of opportunistic diseases, TB culture capacity, and HIV/TB drug resistance testing.
8) Is the program focused on individual labs, or the whole testing pathway?
It is focused on both, but strongly emphasizes the end-to-end testing pathway at scale: building tiered laboratory networks and specimen referral systems so specimens can move from the right facility to the right lab, be processed correctly, and have results reported quickly and used for patient care and public health action.
9) How is the work organized geographically?
The program is structured around regional support. Grantees may be assigned to work in one of four regions (A, B, C, and D) that collectively cover multiple counties.
10) How many grantees may be selected?
The FOA describes that up to five grantees may be selected. It also notes an expected number of awards as 1 in the posted record, while still describing the broader four-region model, suggesting the posted record may reflect a specific supplement or funding action within a broader program structure.
11) What is expected of a regional grantee?
Each regional grantee is expected to support all technical areas described in the announcement within their assigned region.
12) What is special about Region A?
Region A includes an added national-level responsibility. The grantee assigned to Region A must also support laboratory systems at the National Public Health Laboratory Services and at the Ministry of Health headquarters, combining county/regional implementation with national coordination and standard-setting.
13) What are the main technical areas covered by the FOA?
The FOA describes four technical areas overall, including: (1) broad laboratory systems strengthening; (2) safe and appropriate blood use and haemovigilance (focused on facilities that transfuse patients); (3) biosafety, infection control, occupational health and safety, and medical waste management; and (4) monitoring and evaluation as part of accountability and performance measurement across the work.
14) What does the FOA require related to blood transfusion and haemovigilance?
Grantees are expected to provide technical expertise to improve transfusion practices through establishing hospital transfusion committees at facilities that transfuse patients. These committees serve as internal governance mechanisms to oversee blood ordering, storage, administration practices, adverse event monitoring, and continuous improvement.
15) Why does the FOA emphasize hospital transfusion committees?
The FOA positions transfusion committees as a practical way to reduce preventable transfusion-related harm and to ensure blood products are used appropriately and monitored systematically through a formal governance structure within hospitals.
16) What safety and risk-reduction topics are included?
The FOA includes biosafety, infection control, occupational health and safety, and medical waste management. The intent is to protect laboratory staff, clinicians, patients, and surrounding communities through improved practices, training, appropriate PPE use, safe handling and disposal protocols, and clearer accountability for meeting national standards.
17) What measurable safety outcome is highlighted?
The FOA aims to increase the number of laboratories meeting minimum national biosafety and medical waste standards.
18) What quality framework does the FOA reference for laboratory improvement?
The FOA emphasizes quality management and accreditation using SLIPTA (Strengthening Laboratory Improvements towards Accreditation), a stepwise framework commonly used in Africa to build QMS maturity toward internationally recognized standards.
19) What SLIPTA-related targets are mentioned?
The FOA calls for establishing at least two model SLIPTA laboratories in each county.
20) What accreditation target is mentioned?
The FOA calls for achieving ISO 15189 accreditation for at least two laboratories in each county, reflecting an ambitious laboratory quality goal.
21) What end-of-project outcomes does the FOA emphasize?
Headline outcomes include increased access to quality HIV and TB laboratory tests; stronger quality management and accreditation progress (including SLIPTA and ISO 15189 targets); more laboratories meeting national biosafety and waste management standards; and more health facilities establishing hospital transfusion committees and implementing best practices in transfusion and haemovigilance.
22) Are there additional outcomes beyond the headline outcomes?
Yes. The FOA notes that more detailed short-, intermediate-, and long-term outcomes are included in the program's logic model, which is intended to link activities to measurable results over time.
23) What reporting is required from grantees?
Grantees must provide quarterly activity progress reports and quarterly budget updates to the CDC Kenya team.
24) What formal reviews are required during the project?
Grantees are expected to conduct mid-term and end-term program reviews to assess progress, support course correction, and confirm whether implementation is on track.
25) Does the FOA require evaluation activities beyond routine reporting?
Yes. The FOA explicitly calls for both process and outcome evaluations to measure progress toward goals and objectives across the technical areas, with an expectation that findings will be disseminated and used for program improvement.
26) What is the posted award ceiling?
The published award ceiling is $401,462.
27) When was the opportunity originally posted and what was the application deadline?
The opportunity was originally posted on July 29, 2016. The original application deadline was September 27, 2016, with electronic submissions due by 11:59 p.m. ET.
28) Who is eligible to apply?
Eligibility is described as "Others," with additional clarification referenced in the full eligibility text.
29) What does the FOA mean by "hands-on technical assistance"?
Based on the description provided, hands-on technical assistance refers to practical support to the Government of Kenya and PEPFAR implementing partners to strengthen policies, networks, quality systems, biosafety practices, and reliable testing services, rather than only providing funding without technical engagement.
30) How does the program balance county/regional implementation with national coordination?
The FOA uses a regional model for implementation across counties, while assigning Region A an additional role supporting national institutions (National Public Health Laboratory Services and the Ministry of Health headquarters) to strengthen national coordination and standard-setting alongside regional delivery.
Browse more opportunities from the same category: Health
Next opportunity: Program Expansion Supplement: Supporting HIV and Tuberculosis Response in the Kingdom of Lesotho through District-based Comprehensive Prevention, Care and Treatment Program and Health Systems Strengthening under PEPFAR
Previous opportunity: Notice of Intent to Award, Florida International University Under MCA P16AC00032
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 15440201SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 15440201SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Program Expansion Supplement: Supporting HIV and Tuberculosis Response in the Kingdom of Lesotho through District-based Comprehensive Prevention, Care and Treatment Program and Health Systems Strengthening under PEPFAR Apply for CDC RFA GH15 15480201SUPP16 Funding Number: CDC RFA GH15 15480201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $388,800 |
| Program Expansion Supplement:Reducing New HIV Infections, Strengthening Health & Strategic Information Systems, Capacity Building & Increasing Access to Quality HIV/AIDS services through Support Programs Conducted by the Govt of Botswana under PEPFAR Apply for CDC RFA GH11 11970401SUPP16 Funding Number: CDC RFA GH11 11970401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $425,000 |
| Program Expansion Supplement: Supporting Health Worker Staffing in South Africa under PEPFAR Apply for CDC RFA GH11 11100501SUPP16 Funding Number: CDC RFA GH11 11100501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,360,545 |
| Program Expansion Supplement for District Health System Strengthening and Quality Improvement for Service Delivery in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 12480401SUPP16 Funding Number: CDC RFA GH12 12480401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $310,982 |
| Program Expansion Supplement: Strengthening the SA National Department of Health to implement and evaluate evidence-based public health program, surveillance and disease control efforts under PEPFAR Apply for CDC RFA GH13 13370501SUPP16 Funding Number: CDC RFA GH13 13370501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $13,500,000 |
| Program Expansion Supplement: Strengthening Local Capacity to Deliver Sustainable Quality Assured Universal Coverage of Clinical HIV/TB Services and Provide Central Level Technical Assistance to the NTCP in Swaziland under PEPFAR Apply for CDC RFA GH15 15830201SUPP16 Funding Number: CDC RFA GH15 15830201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $420,148 |
| Program Expansion Supplement: Strengthening HIV/TB Laboratory Quality Management Systems and Services in the Kingdom of Swaziland under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15810201SUPP16 Funding Number: CDC RFA GH15 15810201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,628,300 |
| Program Expansion Supplement: Improving Quality of Care and Health Impact through Sustainable, Integrated, Innovative Information System Technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 12500401SUPP16 Funding Number: CDC RFA GH12 12500401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR Apply for CDC RFA GH11 11520502SUPP16 Funding Number: CDC RFA GH11 11520502SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $876,491 |
| Program Expansion Supplement: Strengthening High Quality Laboratory Services Scale-up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15510201SUPP16 Funding Number: CDC RFA GH15 15510201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,345,600 |
| Program Expansion Supplement: Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa Apply for CDC RFA GH11 11090501SUPP16 Funding Number: CDC RFA GH11 11090501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $15,000,000 |
| Program Expansion Supplement: Technical Assistance Services to Countries Supported by the President's Emergency Plan for HIV/AIDS Relief (PEPFAR) and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Apply for CDC RFA GH13 13680302SUPP16 Funding Number: CDC RFA GH13 13680302SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $900,000 |
| National Hemophilia Program Coordinating Center Apply for HRSA 17 087 Funding Number: HRSA 17 087 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improvement of Laboratory and Clinical Services, and Collaboration across the National HIV and TB Programs in Vietnam under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1711 Funding Number: CDC RFA GH17 1711 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Regional Hemophilia Network Apply for HRSA 17 074 Funding Number: HRSA 17 074 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Polio Eradication and Emergency Response in Priority Countries Apply for CDC RFA GH16 172102CONT17 Funding Number: CDC RFA GH16 172102CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Strengthening Local Capacity to Deliver Sustainable Quality-Assured Universal Coverage of Clinical HIV/TB Services and Provide Central Level Technical Assistance in Swaziland Natl AIDS Program under PEPFAR Apply for CDC RFA GH15 15820201SUPP16 Funding Number: CDC RFA GH15 15820201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $355,549 |
| Cooperative Agreement on Immunization with United Nations Children's Fund (UNICEF) Apply for CDC RFA GH13 13020401SUPP16 Funding Number: CDC RFA GH13 13020401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in SA under PEPFAR Apply for CDC RFA GH11 11540501SUPP16 Funding Number: CDC RFA GH11 11540501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,500,000 |
| Delivering Comprehensive Services to Achieve HIV Epidemic Control in Subnational Units in Nigeria under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1753 Funding Number: CDC RFA GH17 1753 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $200,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 15440201SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.